Postpartum interventions to reduce long-term cardiovascular disease risk in women after hypertensive disorders of pregnancy: a systematic review
NA Lui, G Jeyaram, A Henry - Frontiers in cardiovascular medicine, 2019 - frontiersin.org
NA Lui, G Jeyaram, A Henry
Frontiers in cardiovascular medicine, 2019•frontiersin.orgIntroduction: Hypertensive disorders (HDP) affect~ 7% of pregnancies. Epidemiological
evidence strongly suggests HDP independently increases that individual's risk of later
cardiovascular disease (CVD). Focus on reduction or mitigation of this risk has been limited.
This review seeks to identify trialed interventions to reduce cardiovascular risk after HDP.
Methods: Online medical databases were searched to identify full-text published results of
randomized controlled trials (RCT) in women< 10 years postpartum after HDP that trialed …
evidence strongly suggests HDP independently increases that individual's risk of later
cardiovascular disease (CVD). Focus on reduction or mitigation of this risk has been limited.
This review seeks to identify trialed interventions to reduce cardiovascular risk after HDP.
Methods: Online medical databases were searched to identify full-text published results of
randomized controlled trials (RCT) in women< 10 years postpartum after HDP that trialed …
Introduction: Hypertensive disorders (HDP) affect ~7% of pregnancies. Epidemiological evidence strongly suggests HDP independently increases that individual's risk of later cardiovascular disease (CVD). Focus on reduction or mitigation of this risk has been limited. This review seeks to identify trialed interventions to reduce cardiovascular risk after HDP.
Methods: Online medical databases were searched to identify full-text published results of randomized controlled trials (RCT) in women <10 years postpartum after HDP that trialed interventions to reduce cardiovascular risk. Outcomes sought included cardiovascular disease events, chronic hypertension, and other measures of cardiovascular risk such as obesity, smoking status, diet, and physical activity. Publications from January 2008 to July 2019 were included.
Results: Two RCTs were identified. One, a trial of calcium vs. placebo in 201 women with calcium commenced from the first follow-up visit outside of pregnancy and continued until 20 weeks' gestation if another pregnancy occurred. A non-significant trend toward decreased blood pressure was noted. The second RCT of 151 women tested an online education programme (vs. general information to control group) to increase awareness of risk factors and personalized phone-based lifestyle coaching in women who had a preeclampsia affected pregnancy in the 5 years preceding enrolment. Significant findings included increase in knowledge of CVD risk factors, reported healthy eating and decreased physical inactivity, however adoption of a promoted heart healthy diet and physical activity levels did not differ significantly between groups. Several observational studies after HDP, and one meta-analysis of studies of lifestyle interventions not performed specifically after HDP but used to extrapolate likely benefits of lifestyle interventions, were identified which supported the use of lifestyle interventions. Several ongoing RCTs were also noted.
Discussion: There is a paucity of intervention trials in the early years after HDP to guide evidence-based cardiovascular risk reduction in affected women. Limited evidence suggests lifestyle intervention may be effective, however degree of any risk reduction remains uncertain.
Conclusion: Sufficiently powered randomized controlled trials of appropriate interventions (e.g., lifestyle behavior change, pharmacological) are required to assess the best method of reducing the risk of cardiovascular disease in this at-risk population of women.
![](/scholar/images/qa_favicons/frontiersin.org.png)